These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 378670)

  • 21. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of bronchodilator effects and site of action of fenoterol and ipratropium in chronic obstructive bronchitis].
    Kheir A; Ying Y; Hannhart B; Duvivier C; Peslin R; Polu JM
    Rev Mal Respir; 1993; 10(1):9-15. PubMed ID: 8451502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bronchial response to ultrasonic aerosol in subjects pretreated with beta-2 stimulants].
    Marsico SA; Olivieri D; Tranfa CM; Del Donno M; Giacomelli P; Signoriello G; Marra A
    Arch Monaldi; 1984; 39(1-2):27-36. PubMed ID: 6398035
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiopulmonary effects of clenbuterol in the horse.
    Shapland JE; Garner HE; Hatfield DG
    J Vet Pharmacol Ther; 1981 Mar; 4(1):43-50. PubMed ID: 6818359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A trial of clenbuterol in bronchial asthma.
    Anderson G; Wilkins E
    Thorax; 1977 Dec; 32(6):717-9. PubMed ID: 341407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchodilator effect of Aerochamber and Inspirease in comparison with metered dose inhaler.
    Crimi N; Palermo F; Cacopardo B; Vancheri C; Oliveri R; Palermo B; Mistretta A
    Eur J Respir Dis; 1987 Sep; 71(3):153-7. PubMed ID: 3678415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of clenbuterol on mucociliary transport in healthy horses and horses with chronic obstructive pulmonary disease.
    Turgut K; Sasse HH
    Vet Rec; 1989 Nov; 125(21):526-30. PubMed ID: 2595990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: A crossover, placebo-controlled comparison of onset and duration of action.
    Celik G; Kayacan O; Beder S; Durmaz G
    Respiration; 1999; 66(5):434-9. PubMed ID: 10516540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressive effect of clenbuterol on citric acid-induced cough reflex in guinea pigs.
    Horiuchi H; Nonaka T; Ito M; Kaniwa T; Kishimoto T; Fuchikami J; Kohjimoto Y; Kiyoki M
    Res Commun Mol Pathol Pharmacol; 1995 Jun; 88(3):293-301. PubMed ID: 8564385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Action of 3 beta-mimetic bronchodilators: clenbuterol, hexoprenaline, fenoterol. Comparative study].
    Villate Navarro JI; Sobradillo Peña V; Atxotegui Iraola-Goitia V; Uresandi Romero F; Sánchez García J
    Rev Clin Esp; 1980 Sep; 158(5):215-8. PubMed ID: 7001578
    [No Abstract]   [Full Text] [Related]  

  • 32. Disappearance of the decrease in biting behavior induced by clenbuterol, a beta-adrenergic agonist, after chronic administration.
    Frances H; Danti S; Puech AJ; Simon P
    Pharmacol Biochem Behav; 1984 Aug; 21(2):313-6. PubMed ID: 6541345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of carbuterol and hexoprenaline aerosol in bronchial asthma.
    Irsigler GB; Ker J
    S Afr Med J; 1978 Apr; 53(15):571-3. PubMed ID: 354041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The site of action of beta-2-sympathomimetic bronchodilatators in patients with chronic obstructive airway disease.
    Nassari W; Zimmermann I; Bouzrina S; Ulmer WT
    Respiration; 1981; 41(4):232-8. PubMed ID: 7302389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and pharmacodynamics of beta 2-agonists (in the light of fenoterol).
    Schmidt EW; Ulmer WT; Rominger KL
    Respiration; 1995; 62(4):190-200. PubMed ID: 8578014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a beta adrenergic drug and a secretolytic agent on regional mucociliary clearance in patients with COLD.
    Weiss T; Dorow P; Felix R
    Chest; 1981 Dec; 80(6 Suppl):881-5. PubMed ID: 7030660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of a beta 2-agonist (clenbuterol), and anti-bacterial drugs (trimethoprim with sulphadiazine; oxytetracycline) on calf mucociliary clearance.
    Davies CP; Webster AJ
    J Vet Pharmacol Ther; 1989 Jun; 12(2):217-24. PubMed ID: 2746727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratracheal clenbuterol in the horse: its pharmacological efficacy and analytical detection.
    Harkins JD; Robinson NE; Woods WE; Lehner AF; Smith MD; Gates RS; Fisher M; Tobin T
    J Vet Pharmacol Ther; 2000 Aug; 23(4):251-60. PubMed ID: 11106998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of clenbuterol on histamine-induced airway obstruction in ponies.
    Derksen FJ; Scott JS; Slocombe RF; Robinson NE
    Am J Vet Res; 1987 Mar; 48(3):423-6. PubMed ID: 3565899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchodilating activity of oral clenbuterol in asthmatic children after single administration of different dosages.
    Boner AL; Bennati D; Castellani C; Sette L; Schiassi M
    Pediatr Pulmonol; 1987; 3(1):34-7. PubMed ID: 3588048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.